Altshuler Shaham LTD Regeneron Pharmaceuticals, Inc. Transaction History

Altshuler Shaham LTD

  • $1.57 Billion
  • Q3 2024

A detailed history of Altshuler Shaham LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Altshuler Shaham LTD holds 18 shares of REGN stock, worth $12,860. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18
Holding current value
$12,860
% of portfolio
0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$1024.09 - $1201.76 $18,433 - $21,631
18 New
18 $18,000
Q2 2023

Jul 24, 2023
SELL
$700.03 - $830.35 $92,403 - $109,606
-132 Reduced 24.26%
412 $296,000
Q1 2023

May 09, 2023
SELL
$680.49 - $826.97 $72,131 - $87,658
-106 Reduced 16.31%
544 $446,000
Q4 2022

May 09, 2023
SELL
$705.89 - $766.39 $194,825 - $211,523
-276 Reduced 29.81%
650 $468,000
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $163,581 - $206,431
-285 Reduced 23.53%
926 $641,000
Q2 2022

Aug 10, 2022
BUY
$548.35 - $738.84 $582,347 - $784,648
1,062 Added 712.75%
1,211 $716,000
Q1 2022

May 16, 2022
SELL
$595.12 - $698.43 $27,970 - $32,826
-47 Reduced 23.98%
149 $104,000
Q4 2021

Feb 15, 2022
SELL
$543.48 - $670.97 $81.5 Million - $101 Million
-149,984 Reduced 99.87%
196 $124,000
Q3 2021

Nov 15, 2021
BUY
$574.03 - $680.96 $85.7 Million - $102 Million
149,259 Added 16206.19%
150,180 $146,000
Q2 2021

Aug 16, 2021
BUY
$472.8 - $558.54 $60,045 - $70,934
127 Added 15.99%
921 $515,000
Q1 2021

May 13, 2021
SELL
$446.73 - $548.2 $17,422 - $21,379
-39 Reduced 4.68%
794 $376,000
Q4 2020

Feb 16, 2021
SELL
$478.3 - $607.98 $578,743 - $735,655
-1,210 Reduced 59.23%
833 $402,000
Q3 2020

Nov 10, 2020
BUY
$544.75 - $658.21 $693,466 - $837,901
1,273 Added 165.32%
2,043 $1.14 Million
Q2 2020

Aug 13, 2020
BUY
$493.32 - $643.92 $341,377 - $445,592
692 Added 887.18%
770 $480,000
Q1 2020

May 12, 2020
SELL
$336.18 - $494.43 $1.12 Million - $1.64 Million
-3,327 Reduced 97.71%
78 $38,000
Q4 2019

Feb 11, 2020
BUY
$274.13 - $376.51 $933,412 - $1.28 Million
3,405 New
3,405 $1.28 Million
Q3 2019

Nov 12, 2019
SELL
$273.46 - $318.39 $1.21 Million - $1.41 Million
-4,424 Closed
0 $0
Q2 2019

Aug 06, 2019
BUY
$299.6 - $414.82 $1.31 Million - $1.82 Million
4,379 Added 9731.11%
4,424 $1.39 Million
Q1 2019

May 15, 2019
BUY
$372.08 - $439.57 $8,929 - $10,549
24 Added 114.29%
45 $18,000
Q4 2018

Feb 11, 2019
BUY
$335.82 - $403.04 $7,052 - $8,463
21 New
21 $8,000
Q1 2018

May 15, 2018
SELL
$315.82 - $393.78 $1.81 Million - $2.26 Million
-5,731 Closed
0 $0
Q4 2017

May 14, 2018
BUY
$358.63 - $469.95 $2.06 Million - $2.69 Million
5,731
5,731 $2.16 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Altshuler Shaham LTD Portfolio

Follow Altshuler Shaham LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

News

Stay updated on Altshuler Shaham LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email